top of page
Browse by category
Search
WL Gore launches Gore SYNECOR preperitoneal biomaterial in Europe, the Middle East and South Africa
WL Gore & Associates (Gore) has announced that GORE SYNECOR Preperitoneal Biomaterial is now available in Europe, Middle East and South...
FDA approves Soleno’s VYKAT XR to treat hyperphagia in Prader-Willi Syndrome
The FDA has approved Soleno Therapeutics’ VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the...
Palatin's oral MC4R Agonist PL7737 receives FDA Orphan Drug Designation for obesity due to leptin receptor deficiency
Palatin Technologies has announced the FDA has granted "orphan drug" designation to PL7737, an oral treatment that activates the...
United Biotechnology and Novo Nordisk agree license for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
The United Laboratories International Holdings Limited’s (TUL) wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd....
Moon Surgical receives FDA clearance for ScoPilot AI app to run on Maestro surgical robotic system
Moon Surgical has received FDA clearance for its ScoPilot, the first Artificial Intelligence (AI) application to run intraoperatively on...
Roche and Zealand Pharma to co-develop and co-commercialise petrelintide for metabolic diseases
Roche and Zealand Pharma have entered into an exclusive collaboration and licensing agreement to co-develop and co-commercialise...
GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
VIVUS launches QSYMIA in the UAE
VIVUS has received market approval of QSYMIA (phentermine and topiramate extended-release capsules) CIV in the United Arab Emirates (UAE)...
The Obesity Society commends FDA's resolution of obesity drug shortages and calls for enforcement against unauthorised compounding
The Obesity Society (TOS) has acknowledged the FDA’s recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and...
ReShape signs distribution agreement in Canada with Liaison Medical for its next-generation Lap-Band 2.0 FLEX
ReShape Lifesciences has signed a distribution agreement with Liaison Medical for distribution of ReShape’s next generation, enhanced...
Browse by tag
bottom of page